New antibody trial offers hope for Tough-to-Treat cancers
Disease control
Ongoing
This study is testing a new antibody drug called LM-108, given alone or with other cancer treatments, in people with advanced solid tumors that have stopped responding to standard therapies. The main goals are to find a safe dose and see if the treatment can shrink tumors. It inv…
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC